Profile change history

What changed for Nafarelin?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Nafarelin identity.

28Total events
28Record additions
0Version changes
9Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 28 connected records →

Showing the latest 28 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 16, 2026.

Record added

ClinicalTrials.gov record NCT00034047

PeptideScanner retained ClinicalTrials.gov record NCT00034047 at 2026-11-16T01:35:57.709Z. Its registry update date was 2008-01-25, and PeptideScanner's reviewed identity mapping was nafarelin.

PeptideScanner change date
November 16, 2026
Cited source date
January 25, 2008
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02865681

PeptideScanner retained ClinicalTrials.gov record NCT02865681 at 2026-11-16T01:35:57.709Z. Its registry update date was 2019-03-19, and PeptideScanner's reviewed identity mapping was nafarelin.

PeptideScanner change date
November 16, 2026
Cited source date
March 19, 2019
Evidence lane
Clinical trials
Record added

Clinical use of nafarelin in the treatment of leiomyomas. A review of the literature.

PubMed lists PMID 10900582 in The Journal of reproductive medicine as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2000-06 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Ovarian hyperstimulation after the sole use of a gonadotrophin-releasing hormone agonist (Nafarelin) as a complication of in vitro fertilisation treatment.

PubMed lists PMID 11495415 in Journal of assisted reproduction and genetics as Case Reports, Journal Article, with publication-date metadata of 2001-06 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
May 15, 2019
Evidence lane
Literature metadata
Record added

[Nafarelin acetate (Synarel) and thermocoagulation in the treatment of endometriosis].

PubMed lists PMID 11526758 in Ginekologia polska as Clinical Trial, English Abstract, Journal Article, with publication-date metadata of 2001-05 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
March 3, 2017
Evidence lane
Literature metadata
Record added

Nafarelin in the management of endometriosis: quality of life assessment.

PubMed lists PMID 1531576 in American journal of obstetrics and gynecology as Comparative Study, Journal Article, Review, with publication-date metadata of 1992-02 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
June 15, 2019
Evidence lane
Literature metadata
Record added

On the origin and significance of serum CA-125 concentrations in 97 patients with endometriosis before, during, and after buserelin acetate, nafarelin, or danazol.

PubMed lists PMID 1533376 in Fertility and sterility as Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 1992-05 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
July 7, 2019
Evidence lane
Literature metadata
Record added

[Some possibilities for application of "Pfizer" medicines--Prostin 15m, Prostin E2, Prepidil gel, Dostinex, Synarel--in the obstetrician practice].

PubMed lists PMID 18173008 in Akusherstvo i ginekologiia as Journal Article, Review, with publication-date metadata of 2007 (year precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol.

PubMed lists PMID 1834049 in The Australian & New Zealand journal of obstetrics & gynaecology as Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 1991-05 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
August 28, 2019
Evidence lane
Literature metadata
Record added

Longitudinal precision of dual-energy x-ray absorptiometry in a multicenter study. The Nafarelin/Bone Study Group.

PubMed lists PMID 2028837 in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research as Clinical Trial, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 1991-02 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 15, 2007
Evidence lane
Literature metadata
Record added

Nafarelin: a new medical therapy for endometriosis.

PubMed lists PMID 2137620 in Progress in clinical and biological research as Clinical Trial, Comparative Study, Journal Article, Multicenter Study, with publication-date metadata of 1990 (year precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Nafarelin in the treatment of pelvic pain caused by endometriosis.

PubMed lists PMID 2137972 in American journal of obstetrics and gynecology as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1990-02 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
June 15, 2019
Evidence lane
Literature metadata
Record added

Comparison of the pharmacology of nafarelin and danazol.

PubMed lists PMID 2137975 in American journal of obstetrics and gynecology as Comparative Study, Journal Article, Review, with publication-date metadata of 1990-02 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
June 15, 2019
Evidence lane
Literature metadata
Record added

Nafarelin versus danazol in the treatment of endometriosis.

PubMed lists PMID 2137976 in American journal of obstetrics and gynecology as Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, with publication-date metadata of 1990-02 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
June 15, 2019
Evidence lane
Literature metadata
Record added

A comparison of nafarelin acetate and danazol in the treatment of endometriosis.

PubMed lists PMID 2140996 in Fertility and sterility as Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 1990-06 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
July 7, 2019
Evidence lane
Literature metadata
Record added

An attempt to alter the pathophysiology of polycystic ovary syndrome using a gonadotrophin hormone releasing hormone agonist--Nafarelin.

PubMed lists PMID 2533526 in Clinical endocrinology as Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 1989-09 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 9, 2026
Evidence lane
Literature metadata
Record added

Role of nafarelin in the management of endometriosis.

PubMed lists PMID 2533616 in The Journal of reproductive medicine as Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 1989-12 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Clinical experience treating endometriosis with nafarelin.

PubMed lists PMID 2533617 in The Journal of reproductive medicine as Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 1989-12 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Experience in the use of nafarelin for treatment of benign breast disease.

PubMed lists PMID 2535115 in British journal of clinical practice. Supplement as Clinical Trial, Journal Article, with publication-date metadata of 1989-11 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Absorption and metabolism of nafarelin, a potent agonist of gonadotropin-releasing hormone.

PubMed lists PMID 2970910 in Clinical pharmacology and therapeutics as Clinical Trial, Comparative Study, Journal Article, with publication-date metadata of 1988-09 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
May 10, 2019
Evidence lane
Literature metadata
Record added

Endometriosis with a pleural effusion and ascites. Report of a case treated with nafarelin acetate.

PubMed lists PMID 7473446 in The Journal of reproductive medicine as Case Reports, Journal Article, with publication-date metadata of 1995-07 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 23, 2016
Evidence lane
Literature metadata
Record added

[The use of Synarel (nafarelin acetate--spray) in gynecology].

PubMed lists PMID 7485786 in Akusherstvo i ginekologiia as Journal Article, with publication-date metadata of 1994 (year precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 16, 2017
Evidence lane
Literature metadata
Record added

Severe hyperkalaemia with nafarelin.

PubMed lists PMID 8569395 in Lancet (London, England) as Case Reports, Letter, with publication-date metadata of 1996-02-03 (day precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
June 11, 2019
Evidence lane
Literature metadata
Record added

Iontophoresis of nafarelin across human skin in vitro.

PubMed lists PMID 8860440 in Pharmaceutical research as Journal Article, Research Support, U.S. Gov't, P.H.S., with publication-date metadata of 1996-05 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
August 18, 2019
Evidence lane
Literature metadata
Record added

A double-blind randomized study of the treatment of endometriosis with nafarelin or nafarelin plus norethisterone.

PubMed lists PMID 9209899 in Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology as Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1997-06 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 2, 2019
Evidence lane
Literature metadata
Record added

Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis.

PubMed lists PMID 9389816 in Fertility and sterility as Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 1997-11 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
July 7, 2019
Evidence lane
Literature metadata
Record added

Pre or post-operative medical treatment with nafarelin in stage III-IV endometriosis: a French multicenter study.

PubMed lists PMID 9720832 in European journal of obstetrics, gynecology, and reproductive biology as Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 1998-08 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
August 16, 2019
Evidence lane
Literature metadata